Long-term survival in patients (pts) with locally advanced or disseminated malignant melanoma (MM) or renal cell carcinoma (RCC), treated with tag-7 gene-modified (GMV) tumor cells: A phase II trial.

A. V. Novik,Danilova Ab,I. A. Baldueva,Maksim Ivanovich Sluzhev,Tatyana Leonidovna Nehaeva,S. S. Larin,Svetlana Protsenko,A. I. Semenova,Danilov Ao,Vladimir Moiseyenko,Georgii P. Georgiev

Long-term survival in patients (pts) with locally advanced or disseminated malignant melanoma (MM) or renal cell carcinoma (RCC), treated with tag-7 gene-modified (GMV) tumor cells: A phase II trial.

2019

A. V. Novik
Danilova Ab
I. A. Baldueva
Maksim Ivanovich Sluzhev
Tatyana Leonidovna Nehaeva
S. S. Larin
Svetlana Protsenko
A. I. Semenova
Danilov Ao
Vladimir Moiseyenko
Georgii P. Georgiev

e14022Background: Immunotherapy may produce long lasting effects on survival.Magnitude of efficacy may be depended from immune factors. We evaluated the overall survival (OS) in pts treated with GM...

Keywords:

Melanoma
Cancer research
Gene
Renal cell carcinoma
Pathology
Medicine
Immunotherapy
long term survival
locally advanced
tumor cells
in patient
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations